135 related articles for article (PubMed ID: 16647097)
21. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
22. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
Gupta N; Thakker S; Verma SC
Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
[TBL] [Abstract][Full Text] [Related]
23. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP
Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
[TBL] [Abstract][Full Text] [Related]
24. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
[TBL] [Abstract][Full Text] [Related]
25. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter.
Cloutier N; Flamand L
J Biol Chem; 2010 Mar; 285(10):7208-21. PubMed ID: 20048166
[TBL] [Abstract][Full Text] [Related]
26. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.
Juillard F; de Miranda MP; Li S; Franco A; Seixas AF; Liu B; Álvarez ÁL; Tan M; Szymula A; Kaye KM; Simas JP
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22443-22451. PubMed ID: 32820070
[TBL] [Abstract][Full Text] [Related]
27. Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.
Campbell M; Chang PC; Huerta S; Izumiya C; Davis R; Tepper CG; Kim KY; Shevchenko B; Wang DH; Jung JU; Luciw PA; Kung HJ; Izumiya Y
J Biol Chem; 2012 Feb; 287(8):5806-18. PubMed ID: 22179613
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region.
Su L; Liao Q; Wu Y; Chen X
PLoS One; 2011 Apr; 6(4):e19106. PubMed ID: 21544244
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of the chromatin binding domain of KSHV LANA.
Woodard C; Shamay M; Liao G; Zhu J; Ng AN; Li R; Newman R; Rho HS; Hu J; Wan J; Qian J; Zhu H; Hayward SD
PLoS Pathog; 2012; 8(10):e1002972. PubMed ID: 23093938
[TBL] [Abstract][Full Text] [Related]
30. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.
Burnside KL; Ryan JT; Bielefeldt-Ohmann H; Gregory Bruce A; Thouless ME; Tsai CC; Rose TM
Virology; 2006 Oct; 354(1):103-15. PubMed ID: 16879850
[TBL] [Abstract][Full Text] [Related]
31. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
33. KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.
Bentz GL; Bheda-Malge A; Wang L; Shackelford J; Damania B; Pagano JS
Virology; 2014 Jan; 448():293-302. PubMed ID: 24314660
[TBL] [Abstract][Full Text] [Related]
34. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.
Kelley-Clarke B; Ballestas ME; Komatsu T; Kaye KM
Virology; 2007 Jan; 357(2):149-57. PubMed ID: 16979209
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
Ohsaki E; Ueda K; Sakakibara S; Do E; Yada K; Yamanishi K
J Virol; 2004 Sep; 78(18):9936-46. PubMed ID: 15331727
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation.
Cai Q; Xiao B; Si H; Cervini A; Gao J; Lu J; Upadhyay SK; Verma SC; Robertson ES
PLoS Pathog; 2012; 8(3):e1002566. PubMed ID: 22396649
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.
Fujimuro M; Liu J; Zhu J; Yokosawa H; Hayward SD
J Virol; 2005 Aug; 79(16):10429-41. PubMed ID: 16051835
[TBL] [Abstract][Full Text] [Related]
39. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest.
An FQ; Compitello N; Horwitz E; Sramkoski M; Knudsen ES; Renne R
J Biol Chem; 2005 Feb; 280(5):3862-74. PubMed ID: 15525642
[TBL] [Abstract][Full Text] [Related]
40. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.
Verma SC; Borah S; Robertson ES
J Virol; 2004 Oct; 78(19):10348-59. PubMed ID: 15367601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
